Xiao X, Mohamood AS, Uddin S, Gutfreund R, Nakata C, Marshall A, Kimura H, Caturegli P, Hamad AR. Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development. Am J Pathol. 2011 Aug;179(2):725-32.
Shipitsin M, Campbell LL, Argani P, […], Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K. Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007 Mar;11(3):259-73.
Vandenbussche CJ, Elwood H, Cimino-Mathews A, Bittar Z, Illei PB, Warzecha HN. Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype. Hum Pathol. 2013 Nov;44:2487-93.
Vang R, Visvanathan K, Gross A, […], Yemelyanova A, Shih IeM, Shaw PA, Soslow RA, Kurman RJ. Validation of an algorithm for the diagnosis of serous tubal intraepithelial carcinoma. Int J Gynecol Pathol. 2012 May;31(3):243-53
Vang R, Shih IeM, Kurman RJ. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology. 2013 Jan;62(1):44-58.
Vang R, Shih IeM, Kurman RJ. Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009 Sep;16(5):267-82.
Vang R, …, Kurman RJ. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic &…. Am J Surg Pathol. 2008 Nov;32(11):1667-74.
Vang R, […], Ronnett BM. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol. 2006;19:1421-8.
Vang R, Tavassoli FA. Risk for subsequent development of breast cancer. Am J Surg Pathol. 2003 Feb;27(2):268-71.
Mohamood A, Schneck J, Hamad R. Protection from autoimmune diabetes and T cell lymphoproliferation-induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically. Am J Pathol 2007;171:97-106
Ramirez L, Hamad AAR. Status of autoimmune diabetes 20-years after the generation of BDC 2.5 islet reactive TCR transgenic mice. Invited editorial. Word J of Diabetes. 2013 Aug 15; 4(4):88-91.
Ramirez L, Hamad AR. From non-obese diabetic to Network for the Pancreatic Organ Donor with Diabetes: New heights in type 1 diabetes research. World J Diabetes 2015 Nov 25;6(16):1309-11. doi: 10.4239/wjd.v6.i16.1309. PMID:26617973
Pierfelice TJ, Schreck KC, Dang L, Asnaghi L, Gaiano N, Eberhart CG. Notch3 Activation Promotes Invasive Glioma Formation in a Tissue Site-Specific Manner. Cancer Res 2011 Feb 1;71(3):1115-25.
Raabe EH, Lim KS, Kim JM, Meeker A, ..., Eberhart CG. BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model. Clin Cancer Res. 2011 Jun;17(11):3590-9.
Subhawong AP, Nassar H, Halushka MK, Illei PB, Vang R, Argani P. Heterogeneity of Bcl-2 expression in metastatic breast carcinoma. Mod Pathol. 2010 Aug;23(8):1089-96.
Wu JM, Halushka MK, Argani P. Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer. Hum Pathol. 2010 Jun;41(6):914-7
Wu JM, Fackler MJ, […], Ladanyi M, Sukumar S, Argani P. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res.2008;14:1938-46
Subhawong AP, Subhawong T,[…], Argani P. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically. Am J Surg Pathol.2009;33:163-75
Meeker AK, Hicks JL, Gabrielson E, Strauss WM, De Marzo AM, Argani P. Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol. 2004 Mar;164(3):925-35.
Mehrotra J, Vali M, […], Argani P, Sukumar S. Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res. 2004 May 1;10(9):3104-9.
Singhi AD, Cimino-Mathews A, [...], De Marzo AM, Argani P. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors. Mod Pathol. 2012 Mar;25(3):378-87.
Cimino A, Halushka M, Illei P, Wu X, Sukumar S, Argani P. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases. Breast Cancer Res Treat. 2010 Oct;123(3):701-708.
Cimino-Mathews A, [...], De Marzo A, Park BH, Argani P. Androgen receptor expression is usually maintained in initial surgically-resected breast cancer metastases, but often lost in terminal metastases found at autopsy. Human Pathology. 2012;43:1003-11.
Cimino-Mathews A, Subhawong AP, Elwood H, Nassar Warzecha H, [...], Taube JM, Illei PB, Argani PA. Neural crest transcription factor Sox10 is preferentially expressed in triple negative and metaplastic breast carcinomas. Human Pathol. 2013;44:959-65.
Cimino-Mathews A, Subhawong AP, Illei PB, Sharma R, Halushka MK, Vang R, Fetting JH, Park BH, Argani PA. GATA-3 Expression in Breast Carcinoma: Utility in Triple Negative, Sarcomatoid and Metastatic Carcinomas. Human Pathol. 2013 Jul;44:1341-9.
VandenBussche CJ, Khouri N, [...], Tatsas A, Cimino-Mathews A, Argani P. Borderline atypical duct hyperplasia/low grade ductal carcinoma in situ on breast needle core biopsy should be managed conservatively. Am J Surg Pathol. 2013;37:913-23.
Cimino-Mathews A, Hicks JL, Sharma R, Vang R, Illei PB, De Marzo A, Emens LA, Argani P. A Subset of Malignant Phyllodes Tumors Harbors Alterations in the Rb/p16 Pathway. Human Pathol. 2013 Nov;44(11):2494-500.
Cimino-Mathews A, Ye X, Meeker A, Argani P, Emens LA. Metastatic Triple Negative Breast Cancers at First Relapse Have Fewer Tumor-Infiltrating Lymphocytes Than Their Matched Primary Breast Tumors: A Pilot Study. Human Pathol. 2013 Oct;44:2055-63.
Beaver JA, Jelovac D,[...], Cimino-Mathews A, Argani P, Wolff AC,Park BH. Detection of cancer specific mutations in plasma of early stage breast cancer patients. Clin Cancer Res. 2014 May;20(10):2643-50.
Asch-Kendrick RJ, Samols MA, Lilo MT, Subhawong A, Sharma R, Illei PB, Argani P, Cimino-Mathews A. NKX3.1 is expressed in ER and AR positive primary breast carcinomas. J Clin Pathol. 2014 Sep;67(9):768-71.
Carney E, Cimino-Mathews A, Argani C, Kronz J, Vang R, Argani P. A subset of nondescript axillary lymph node inclusions represent endosalpingiosis. Am J Surg Pathol. 2014 Dec;38(12):1612-7
Vandenbussche C, Cimino-Mathews A, [...] Argani P. Reflex ER/PR/Her2 analysis of breast cancers in needle core biopsy specimens dramatically increases health care costs. Am J Surg Pathol. 2015 Jul;39:939-47
Poling JS, Tsangaris TN, Argani P, Cimino-Mathews A. Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases. Breast Cancer Res Treat. 2014 Nov;148(2):355-61.
Cimino-Mathews A, Foote JB, Emens LA. Immune targeting in breast cancer. Oncology (Williston Park). 2015 May;29:375-85.
Heaphy CM, Asch-Kendrick R, Argani P, Meeker AK, Cimino-Mathews A. Telomere Length Alterations Unique to Invasive Lobular Carcinoma. Hum Pathol. 2015 Aug;46(8):1197-203.
Cimino-Mathews A, Sharma R, Illei PB, Vang R, Argani P. A Subset of Malignant Phyllodes Tumors Express p63 and p40: A Diagnostic Pitfall in Breast Core Needle Biopsies. Amer J Surg Pathol. 2014 Dec;38(12):1689-96.
White MJ, Hazard SW 3rd, Frank SM, Boyd JS, Wick EC, Ness PM, Tobian AA. The evolution of perioperative transfusion testing and blood ordering. Anesth Analg. 2015 Jun;120(6):1196-203.
Subhawong AP, Heaphy CM, Argani P, Konishi Y, Kouprina N, Nassar H, Vang R, Meeker AK. The alternative lengthening of telomeres phenotype in breast carcinoma is associated with HER-2 overexpression. Mod Pathol. 2009;22:1423-31.
